Literature DB >> 11756685

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.

Yaacov Barak1, Debbie Liao, Weimin He, Estelita S Ong, Michael C Nelson, Jerrold M Olefsky, Richard Boland, Ronald M Evans.   

Abstract

Targeting of the nuclear prostaglandin receptor peroxisome proliferator-activated receptor delta (PPARdelta) by homologous recombination results in placental defects and frequent (>90%) midgestation lethality. Surviving PPARdelta(-/-) mice exhibit a striking reduction in adiposity relative to wild-type levels. This effect is not reproduced in mice harboring an adipose tissue-specific deletion of PPARdelta, and thus likely reflects peripheral PPARdelta functions in systemic lipid metabolism. Finally, we observe that PPARdelta is dispensable for polyp formation in the intestine and colon of APC(min) mice, inconsistent with its recently proposed role in the establishment of colorectal tumors. Together, these observations reveal specific roles for PPARdelta in embryo development and adipocyte physiology, but not cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756685      PMCID: PMC117556          DOI: 10.1073/pnas.012610299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

Review 3.  Inducible gene targeting in mice using the Cre/lox system.

Authors:  B Sauer
Journal:  Methods       Date:  1998-04       Impact factor: 3.608

4.  Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta.

Authors:  H Lim; R A Gupta; W G Ma; B C Paria; D E Moller; J D Morrow; R N DuBois; J M Trzaskos; S K Dey
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

5.  PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.

Authors:  T C He; T A Chan; B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

6.  Activation of PPARdelta alters lipid metabolism in db/db mice.

Authors:  M D Leibowitz; C Fiévet; N Hennuyer; J Peinado-Onsurbe; H Duez; J Bergera; C A Cullinan; C P Sparrow; J Baffic; G D Berger; C Santini; R W Marquis; R L Tolman; R G Smith; D E Moller; J Auwerx
Journal:  FEBS Lett       Date:  2000-05-19       Impact factor: 4.124

7.  Expression of peroxisome proliferator-activated receptor PPARdelta promotes induction of PPARgamma and adipocyte differentiation in 3T3C2 fibroblasts.

Authors:  C Bastie; D Holst; D Gaillard; C Jehl-Pietri; P A Grimaldi
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

8.  Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality.

Authors:  M Hesse; T Franz; Y Tamai; M M Taketo; T M Magin
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

9.  Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).

Authors:  J M Peters; S S Lee; W Li; J M Ward; O Gavrilova; C Everett; M L Reitman; L D Hudson; F J Gonzalez
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

10.  Cytokeratins 8 and 19 in the mouse placental development.

Authors:  Y Tamai; T Ishikawa; M R Bösl; M Mori; M Nozaki; H Baribault; R G Oshima; M M Taketo
Journal:  J Cell Biol       Date:  2000-10-30       Impact factor: 10.539

View more
  184 in total

Review 1.  Crosstalk of oncogenic and prostanoid signaling pathways.

Authors:  Rolf Müller
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

Review 2.  Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface.

Authors:  Kristy Red-Horse; Yan Zhou; Olga Genbacev; Akraporn Prakobphol; Russell Foulk; Michael McMaster; Susan J Fisher
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

3.  Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-δ/β overexpression.

Authors:  Xiangsheng Zuo; Min Xu; Jiang Yu; Yuanqing Wu; Micheline J Moussalli; Ganiraju C Manyam; Sun Il Lee; Shoudan Liang; Mihai Gagea; Jeffrey S Morris; Russell R Broaddus; Imad Shureiqi
Journal:  J Natl Cancer Inst       Date:  2014-03-28       Impact factor: 13.506

Review 4.  Role of nuclear receptors in blastocyst implantation.

Authors:  Y M Vasquez; F J DeMayo
Journal:  Semin Cell Dev Biol       Date:  2013-08-28       Impact factor: 7.727

Review 5.  Peroxisome proliferator-activated receptor-delta, a regulator of oxidative capacity, fuel switching and cholesterol transport.

Authors:  C Fürnsinn; T M Willson; B Brunmair
Journal:  Diabetologia       Date:  2006-11-22       Impact factor: 10.122

6.  Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Clement Richard Boland
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

7.  Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes.

Authors:  Cécile Calléja; Nadia Messaddeq; Benoit Chapellier; Haiyuan Yang; Wojciech Krezel; Mei Li; Daniel Metzger; Bénédicte Mascrez; Kiminori Ohta; Hiroyuki Kagechika; Yasuyuki Endo; Manuel Mark; Norbert B Ghyselinck; Pierre Chambon
Journal:  Genes Dev       Date:  2006-06-01       Impact factor: 11.361

Review 8.  Involvement of PPAR nuclear receptors in tissue injury and wound repair.

Authors:  Liliane Michalik; Walter Wahli
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

9.  Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta.

Authors:  Karim Nadra; Silvia I Anghel; Elisabeth Joye; Nguan Soon Tan; Sharmila Basu-Modak; Didier Trono; Walter Wahli; Béatrice Desvergne
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 10.  Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

Authors:  O C Trifan; T Hla
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.